Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 254: Inflammation as a predictor of HIV disease progression
Predictive value of inflammatory biomarkers in untreated HIV disease progression, and their response to initiation of antiretroviral therapy
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 236: HPV vaccine in HIV positive girls and women
A study of an HPV VLP vaccine in a cohort of HIV positive girls and women
-
CTN 281: EPIC 4 Study
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
-
CTN 318: Sexual Confidence Randomized Controlled Trial
Integrating cognitive-behavioural therapy for social anxiety disorder with HIV risk reduction counselling for HIV-negative gay and bisexual men who are at high risk for HIV
-
CTN 292A: Screening for high-grade anal dysplasia in HIV+ MSM
Development and validation of an anal cancer screening algorithm in HIV-positive men who have sex with men (MSM) – part of HPV-SAVE study.
-
CTN 292B: Treatment of high-grade anal dysplasia in HIV+ MSM
A randomized controlled, open-label trial examining the efficacy, safety, and tolerability of ablative therapies for high-grade anal dysplasia versus observation alone in HIV-positive men who have sex with men (MSM) – part of HPV-SAVE study.
-
CTN 300: The Engage Cohort Study
HIV Prevention for Gay, Bisexual, and other Men Who Have Sex with Men
-
-
CTN 317: Transgender Education for Affirmative and Competent HIV and Healthcare (TEACHH)
Transgender women removing healthcare barriers to engagement in the HIV prevention and care cascades
-
CTN 308: Estrogen and Probiotic Treatment for Vaginal Health
Improving vaginal health to decrease biological risk of HIV-1 infection in Canadian ACB women
-
CTN 315: The KIND Study
Kids Imaging and Neurocognitive Development (KIND) Thanks to advances in treatment, many women living with HIV can get pregnant with minimal risk of giving birth to a child who has the virus. While most children who are HIV-exposed but uninfected (CHEU) are in good health, it is unclear how exposure to HIV and antiretroviral therapy…
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More